Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TREASURE: Tenecteplase Before Transfer for EVT in Acute Ischemic Stroke
NCT07253181Phase 3Recruiting
- Sponsor
- Xuanwu Hospital
- Start
- Jan 2026
- Primary completion
- Mar 2028
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in ischemic stroke comparing Tenecteplase before transfer with Standard of care (2 arms). Primary endpoint: Modified Rankin Scale at 90 days. Started Jan 2026; status: recruiting.
02
Drugs
tenecteplase
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT07253181.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07253181.